Maxwell John T. 4
4 · Aquestive Therapeutics, Inc. · Filed Dec 7, 2018
Insider Transaction Report
Form 4
Maxwell John T.
SVP-Chief Financial Officer
Transactions
- Purchase
Common Stock
2018-12-06$8.87/sh+5,000$44,350→ 153,614 total
Footnotes (1)
- [F1]Includes 10,000 shares owned jointly with Mr. Maxwell's spouse.